Variations in the concentrations of the immunoglobulins IgG1, IgG2, IgM and IgA in sheep. 2. Changes in the blood of lambs of different breeds and crossbreeds during the course of the rearing period

The sera of 188 lambs from seven breed groups were analyzed for the concentrations of IgG1, IgG2, IgM and IgA by radial immunodiffusion using monospecific antibodies. From each lamb, 14 blood samples were drawn before and 5 samples after weaning. The following results were obtained: 1. Immunoglobulins could not be detected in sera drawn before the first intake of colostrum. 2. In normally suckling lambs, the peak concentrations of maternal immunoglobulins are attained at 0-18 hrs after birth. They can be assessed in a single blood sample drawn between 18 and 24 hrs. 3. The half-life times of maternal immunoglobulin in lamb sera are 11 days for IgG1, 7 days for IgG2, 6 days for IgM and 18 hours for IgA. 4. The absolute peak heights relate to the amounts of colostrum ingested before 12-18 hrs after birth. 5. The decline of maternal immunoglobulins in lamb sera over-laps with the onset of lamb immunoglobulin synthesis. Renewed rises of concentrations are observed for IgG2 after week 2, for IgM after week 3 and for IgG1 after week 7. The concentrations of IgA remain at the low levels characteristic for the serum of grown sheep. 6. The role of immunoglobulin synthesis in suckling lambs is only briefly and to a small extent reduced after weaning.     

Hemagglutination and hemagglutination inhibition of turkey red blood cells with Mycoplasma hyopneumoniae

The ability of Mycoplasma hyopneumoniae to agglutinate RBC was evaluated to develop an in vitro cytadsorption assay. Using swine RBC in a microtitration hemagglutination test, no agglutination or partial agglutination was detected. Comparison of RBC from various other species indicated that improved hemagglutination was obtained with RBC from turkeys. This hemagglutination was detected only when mycoplasma cells used in the assay had been frozen and thawed, heated at 50 C for 30 minutes, or treated with trypsin. Treatment of RBC with trypsin or neuraminidase enhanced hemagglutination. Possible surface lectin activity in M hyopneumoniae was evaluated by use of carbohydrates in a blocking assay; hemagglutination was not inhibited by any of 13 carbohydrates evaluated. Mycoplasma hyopneumoniae convalescent porcine serum and monoclonal antibodies against 2 M hyopneumoniae immunogens of molecular weights of 64,000 and 41,000 inhibited hemagglutination.     

Chicken anemia agent in the United States: isolation of the virus and detection of antibody in broiler breeder flocks

Chicken anemia agent (CAA) was isolated from broiler chickens in Texas with a blue wing or anemia dermatitis-like syndrome. Specific-pathogen-free chicks inoculated with field material developed anemia, and CAA was isolated in MDCC-MSB1 cells from bone marrow and lymphoid tissue from inoculated chicks. One isolate, designated EF88/78/276, was further characterized. Infectivity of EF88/78/276 was resistant to treatment with chloroform and with heat at 70 C for 5 minutes. EF88/78/276 was indistinguishable from the Cux-1 and Gifu-1 isolates of CAA by cross-neutralization tests. Almost all 1-day-old susceptible chicks inoculated intramuscularly with EF88/78/276 developed anemia, but contact-infected chicks did not. Antibody to CAA was detected in broiler breeder flocks from Texas, the Delmarva peninsula, and Alabama.     

Ionophores alter hepatic concentrations of intermediary carbohydrate metabolites in steers

The effects of ionophores on liver weight and function were determined in finishing steers (n = 24; avg weight 440 kg). Steers were group-fed one of three treatments (control, lasalocid or monensin at 33 mg/kg feed) for 46 d prior to slaughter. Three days prior to slaughter, blood was collected for the determination of serum Ca and Mg. At slaughter, the liver was removed, weighed, sampled, frozen in liquid nitrogen and subsequently analyzed for concentrations of carbohydrate metabolites and minerals. Liver weight (5.9 kg) was unaffected by treatment. Serum and hepatic Ca and Mg were not affected by ionophore treatment. Hepatic glycogen levels in steers fed ionophores were unaffected by treatment. Fructose 1,6-bisphosphate was 21% lower (P less than .10) in hepatic tissue of steers fed ionophores, whereas dihydroxyacetone phosphate was 15 to 37% greater in hepatic tissue of steers fed monensin (P less than .20) or lasalocid (P less than .10). Glyceraldehyde 3-phosphate was elevated more extensively by lasalocid than by monensin with increases of 72 (P less than .05) and 132% (P less than .001), respectively, over controls. Glycerol 3-phosphate levels were 37% (P less than .05) and 12% (NS) greater with these ionophores. Hepatic levels of pyruvate were elevated 12 (NS) to 36% (P less than .17) for monensin and lasalocid. Fructose 2,6-bisphosphate levels were 25% lower (P less than .25) in hepatic tissue of steers fed ionophores than in hepatic tissue from control steers. Other metabolites of carbohydrate metabolism in hepatic tissue were not altered appreciably. Changes in levels of intermediary metabolites of carbohydrate metabolism suggest alterations in hepatic carbohydrate metabolism favoring gluconeogenesis in steers fed ionophores.     

Food aversion learning: ability of lambs to distinguish safe from harmful foods

We studied the ability of lambs to select safe foods in the presence of harmful foods. In a series of feeding experiments, 3- to 6-mo-old lambs were offered a choice between 1) a familiar, safe and a novel, harmful food, 2) a novel, safe and a novel, harmful food and 3) a familiar, harmful and a novel, safe food. All harmful foods were palatable feeds that had been treated with lithium chloride (LiCl), a non-lethal gastrointestinal poison. When lambs ingested a meal composed of a novel food containing LiCl and a familiar, safe food, lambs subsequently avoided the novel food. Lambs avoided the novel food even when the familiar food contained LiCl. The response of lambs varied when lambs were given a choice between a novel, safe food and a novel food containing LiCl. Lambs either avoided the novel food containing LiCl and ingested the safe food or they limited their intake of both novel foods. Their response was dependent on the novelty of the food containing LiCl. When a novel, palatable food contained 2% LiCl, lambs always ate some of the food, even after experiencing illness from ingesting it. Lambs experienced with foods containing LiCl displayed greater food neophobia than lambs naive to LiCl-treated foods. Thus, novelty was the major criterion that lambs used to associate foods with gastrointestinal illness.     

IOHEXOL AND IOPAMIDOL MYELOGRAPHY IN THE DOG: A CLINICAL TRIAL COMPARING ADVERSE EFFECTS AND MYELOGRAPHIC QUALITY

In a blind clinical trial, adverse effects after iohexol and iopamidol myelography were evaluated in 151 dogs. Eighty-one dogs were given iohexol (240 mgI/ml) and 70 dogs were given iopamidol (200 mgI/ml) by pre-determined assignment. Each dog was evaluated postmyelographically for seizures, hyperthermia, prolonged recovery from anesthesia and intensification of pre-existing neural signs. Myelographic quality was evaluated with a subjective scoring method. In comparing iohexol and iopamidol groups, there was not a statistically significant difference in the incidence of adverse effects or in myelographic quality. Iopamidol and iohexol appeared to be equally efficacious for routine canine myelography.